| SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS |
The
following tables present the effect of the restatement on the Company’s previously issued condensed consolidated financial statements:
SCHEDULE
OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS
| | |
As Previously
Reported (A) | | |
As
Restated (B) | | |
Difference
(B) - (A) | |
| CONSOLIDATED BALANCE SHEETS | |
| | | |
| | | |
| | |
| As of March 31, 2025 | |
| | | |
| | | |
| | |
Assets: | |
| | | |
| | | |
| | |
| Cash and cash equivalents | |
$ | 26,996,932 | | |
$ | 2,425,391 | | |
| (24,571,541 | ) |
Restricted cash (client funds, segregated) | |
| - | | |
| 17,453,282 | | |
| 17,453,282 | |
| Subscription receivable (asset) | |
| 8,200,000 | | |
| - | | |
| (8,200,000 | ) |
| Right of use (lease) | |
| 668,215 | | |
| 938,131 | | |
| 269,916 | |
| Liabilities: | |
| | | |
| | | |
| | |
| Customer funds / Client funds payable | |
| 24,527,483 | | |
| 17,453,282 | | |
| (7,074,201 | ) |
| Operating lease liability, current | |
| 363,370 | | |
| 186,157 | | |
| (177,213 | ) |
| Operating lease liability, non-current | |
| 304,845 | | |
| 482,056 | | |
| 177,211 | |
| Stockholders’ Equity: | |
| | | |
| | | |
| | |
| Common stock, par value | |
| 42,258 | | |
| 42,308 | | |
| 50 | |
| Additional paid-in capital | |
| 17,938,279 | | |
| 14,262,445 | | |
| (3,675,834 | ) |
| Subscription receivable (contra-equity) | |
| - | | |
| (8,000,000 | ) | |
| (8,000,000 | ) |
| Additional paid-in capital, Series B Preferred stock | |
| - | | |
| 3,344,063 | | |
| 3,344,063 | |
| Accumulated other comprehensive income (loss) | |
| 140,137 | | |
| 120,626 | | |
| (19,511 | ) |
| Accumulated deficit | |
| (2,480,382 | ) | |
| (2,103,290 | ) | |
| 377,092 | |
| Noncontrolling interest | |
| 14,199 | | |
| 14,199 | | |
| - | |
| | |
| | | |
| | | |
| | |
| CONSOLIDATED STATEMENTS OF OPERATIONS | |
| | | |
| | | |
| | |
| Three months ended March 31, 2025 | |
| | | |
| | | |
| | |
| Technology & software | |
| 813,747 | | |
| 813,747 | | |
| - | |
| Wealth management | |
| 1,534,852 | | |
| 1,534,852 | | |
| - | |
| Investment and Brokerage | |
| 3,628,349 | | |
| 3,628,349 | | |
| - | |
| Total revenue | |
| 5,976,948 | | |
| 5,976,948 | | |
| - | |
| Technology & software | |
| 184,284 | | |
| - | | |
| (184,284 | ) |
| Wealth management | |
| 1,349,827 | | |
| 1,349,827 | | |
| - | |
| Investment and Brokerage | |
| 1,583,278 | | |
| 1,767,562 | | |
| 184,284 | |
| Total cost of sales | |
| 3,117,389 | | |
| 3,117,389 | | |
| - | |
| Gross Profit | |
| 2,859,559 | | |
| 2,859,559 | | |
| - | |
| General and administrative | |
| 2,140,270 | | |
| 2,136,678 | | |
| (3,592 | ) |
| Sales and marketing | |
| 276,204 | | |
| 276,204 | | |
| - | |
| Depreciation | |
| 38,832 | | |
| 38,832 | | |
| - | |
| Total operating expenses | |
| 2,455,306 | | |
| 2,451,714 | | |
| (3,592 | ) |
| Operating income (loss) | |
| 404,253 | | |
| 407,845 | | |
| 3,592 | |
| Other income (expense): | |
| | | |
| | | |
| | |
| Other interest expense | |
| 4,483 | | |
| 4,483 | | |
| - | |
| Other income (expense) | |
| (304,188 | ) | |
| (98,206 | ) | |
| 205,982 | |
| Total other income (expense) | |
| (299,705 | ) | |
| (93,723 | ) | |
| 205,982 | |
| | |
| | | |
| | | |
| | |
| CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) | |
| | | |
| | | |
| | |
| Three months ended March 31, 2025 | |
| | | |
| | | |
| | |
| Change in APIC due to common control | |
| 882,771 | | |
| 676,789 | | |
| (205,982 | ) |
| | |
| | | |
| | | |
| | |
| CONSOLIDATED STATEMENTS OF CASH FLOWS | |
| | | |
| | | |
| | |
| Three months ended March 31, 2025 | |
| | | |
| | | |
| | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| | | |
| | | |
| | |
| Depreciation | |
$ | 38,832 | | |
| 38,832 | | |
| - | |
| Fixed assets, net | |
$ | 25,425 | | |
| 25,425 | | |
| - | |
| Net cash provided by (used in) operating activities |
|
|
179,534 |
|
|
|
385,516 |
|
|
|
205,982 |
|
| Investing Activities: |
|
|
|
|
|
|
|
|
|
|
|
|
| Capitalized software |
|
|
(54,234 |
) |
|
|
(54,234 |
) |
|
|
- |
|
| Changes in paid-in capital |
|
|
882,771 |
|
|
|
676,789 |
|
|
|
(205,982 |
) |
| Net
cash used in investing activities |
|
$ |
828,537 |
|
|
|
622,555 |
|
|
|
(205,982 |
) |
| Financing Activities: |
|
|
|
|
|
|
|
|
|
|
|
|
| Borrowing from (payments to) line of credit |
|
|
110,463 |
|
|
|
110,463 |
|
|
|
- |
|
| Net proceeds from cares act - paycheck protection program. |
|
|
(3,272 |
) |
|
|
(3,272 |
) |
|
|
- |
|
| Net proceeds from SBA loan |
|
|
(2,127 |
) |
|
|
(2,127 |
) |
|
|
- |
|
| Related party advances |
|
|
932,932 |
|
|
|
(6,780,895 |
) |
|
|
(7,713,827 |
) |
| Series A Preferred cancelation |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Change in noncontrolling interest |
|
|
(23,931 |
) |
|
|
(21,310 |
) |
|
|
2,621 |
|
| Net cash provided by (used in) financing activities |
|
|
1,014,065 |
|
|
|
(6,699,762 |
) |
|
|
(7,713,827 |
) |
| Effect of exchange rates |
|
|
193,407 |
|
|
|
193,407 |
|
|
|
- |
|
| | |
| | | |
| | | |
| | |
| | |
As Previously Reported (A) | | |
As Restated (B) | | |
Difference (B) - (A) | |
| CONSOLIDATED BALANCE SHEETS | |
| | | |
| | | |
| | |
| As of March 31, 2024 | |
| | | |
| | | |
| | |
| Assets: | |
| | | |
| | | |
| | |
| Cash and cash equivalents | |
$ | 38,945,123 | | |
$ | 1,504,427 | | |
| (37,440,696 | ) |
| Restricted cash (client funds, segregated) | |
| - | | |
| 37,440,696 | | |
| 37,440,696 | |
| Subscription receivable (asset) | |
| 8,200,000 | | |
| - | | |
| (8,200,000 | ) |
| Right of use (lease) | |
| - | | |
| 1,087,104 | | |
| 1,087,104 | |
| Liabilities: | |
| | | |
| | | |
| | |
| Customer funds / Client funds payable | |
| 37,440,696 | | |
| 37,440,696 | | |
| - | |
| Operating lease liability, current | |
| - | | |
| 291,330 | | |
| 291,330 | |
| Operating lease liability, non-current | |
| - | | |
| 668,214 | | |
| 668,214 | |
| Stockholders’ Equity: | |
| | | |
| | | |
| | |
| Common stock, par value | |
| 38,858 | | |
| 38,908 | | |
| 50 | |
| Additional paid-in capital | |
| 13,475,375 | | |
| 13,530,075 | | |
| 54,700 | |
| Subscription receivable (contra-equity) | |
| - | | |
| (8,200,000 | ) | |
| (8,200,000 | ) |
| Additional paid-in capital, Series B Preferred stock | |
| 3,329,964 | | |
| 3,329,964 | | |
| - | |
| Accumulated other comprehensive income (loss) | |
| (17,288 | ) | |
| (17,288 | ) | |
| - | |
| Accumulated deficit | |
| (1,814,907 | ) | |
| (1,742,097 | ) | |
| 72,810 | |
| Noncontrolling interest | |
| 41,053 | | |
| 41,053 | | |
| - | |
| | |
| | | |
| | | |
| | |
| CONSOLIDATED STATEMENTS OF OPERATIONS | |
| | | |
| | | |
| | |
| Three months ended March 31, 2024 | |
| | | |
| | | |
| | |
| General and administrative | |
$ | 2,299,134 | | |
| 2,226,324 | | |
| (72,810 | ) |
| Total operating expenses | |
| 2,386,347 | | |
| 2,313,537 | | |
| (72,810 | ) |
| Operating income (loss) | |
| (44,246 | ) | |
| 28,564 | | |
| 72,810 | |
| Net income (loss) | |
| 833,445 | | |
| 906,255 | | |
| 72,810 | |
|